Skip to content
sellWeak10b5-1 plan

Mark T Hilz sold $16k of HSCS

COO, Secretary and Director at Heart Test Laboratories, Inc.. 4,416 shares at an average of $3.54, traded Jul 29, 2025, filed Jul 30, 2025.

Warning score
10
Value
$16k
4,416 shares
Holdings after
4,752
-48% from before
From 52-week low
-
no price yet
From 52-week high
-
no price yet

Score components

  • Role
    COO
    +20
  • Trade size
    $16k at market
    0
  • Share of holdings sold
    Sold 48% of holdings
    +10
  • Cluster
    No other insider selling within 14 days
    0
  • 10b5-1 plan
    Pre-scheduled under a 10b5-1 plan
    -20

What happened after comparable sells

Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.

This signal so far: 1m +2.4%, 3m -10.8%, 6m -1.8%.

Price around the trade, and since

From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.

HSCSOct 13, 2026 · close 3.09
Since filing Jul 30, 2025: -7.2%SPY +24.3% · excess -31.5%

Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™

Rows in this filing

Every transaction in Form 4 0001213900-25-069530, as filed. Open on EDGAR

DateTransactionSharesPriceValueHoldings afterFiled
Jul 29, 2025SOpen-market sale
Common Stock, $0.001 par value10b5-1
-4,416$3.54$16k4,752Jul 30, 2025

Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.

Mark T Hilz sold $16k of HSCS | InsiderTell